Determines eligibility for prone positioning in ARDS and calculates session parameters. Indicated for severe ARDS with PaO2/FiO2 <150 mmHg on FiO2 ≥0.6, PEEP ≥5 cmH2O, and TV 6 mL/kg IBW after ≥12 hours of optimization. Sessions: minimum 16 hours. PROSEVA trial: 28-day mortality 16% (prone) vs 32.8% (supine) in severe ARDS. Continue daily sessions until PF consistently >150 after resupination.
Enter the values for the scenario you are assessing. Determines eligibility for prone positioning in ARDS and calculates session parameters. Indicated for severe ARDS with PaO2/FiO2 <150 mmHg on FiO2 ≥0.6, PEEP ≥5 cmH2O, and TV 6 mL/kg IBW after ≥12 hours of optimization. Sessions: minimum 16 hours. PROSEVA trial: 28-day mortality 16% (prone) vs 32.8% (supine) in severe ARDS. Continue daily sessions until PF consistently >150 after resupination. Use the prone positioning ards result to inform your calculation.